BRGX (BioRegenx) Accounts Payable : $0.49 Mil (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx Accounts Payable?

BioRegenx's Accounts Payable for the quarter that ended in Sep. 2024 was $0.49 Mil.

BioRegenx's quarterly Accounts Payable declined from Mar. 2024 ($0.61 Mil) to Jun. 2024 ($0.43 Mil) but then increased from Jun. 2024 ($0.43 Mil) to Sep. 2024 ($0.49 Mil).

BioRegenx Accounts Payable Historical Data

The historical data trend for BioRegenx's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Accounts Payable Chart

BioRegenx Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

BioRegenx Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															-	-	0.61	0.43	0.49

BioRegenx Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

BioRegenx Accounts Payable Related Terms

Thank you for viewing the detailed overview of BioRegenx's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRegenx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

7407 Ziegler Road, Chattanooga, TN, USA, 37421

Website

https://www.bioregenx.com

BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.